BDBM238864 2-[(3aR,5S,6aS)-5- benzyl- octahydrocyclopenta[c] pyrrol-2-yl]-1-(4- hydroxyphenyl)ethan-1- onefluorophenol::US10052306, 303

SMILES Oc1ccc(cc1)C(=O)CN1C[C@@H]2C[C@H](Cc3ccccc3)C[C@@H]2C1

InChI Key InChIKey=BAJUYSVVGOEBEF-VJDPLVQDSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 238864   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM238864(2-[(3aR,5S,6aS)-5- benzyl- octahydrocyclopenta[c] ...)
Affinity DataIC50:  38.8nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent